In its second acquisition this year, Nellcor will purchase a privately-owned Canadian manufacturer of sleep diagnostic products used in the sleep lab. Terms of the deal were not disclosed. Melville Software will be integrated in Nellcor's home healthcare subsidiary, EdenTec. "Melville sleep lab products are an excellent strategic fit with EdenTec portable sleep products and the recently acquired Pierre Medical therapeutic products," Nellcor's CEO Raymond Larkin says.
Nellcor adds sleep diagnostics:
In its second acquisition this year, Nellcor will purchase a privately-owned Canadian manufacturer of sleep diagnostic products used in the sleep lab. Terms of the deal were not disclosed. Melville Software will be integrated in Nellcor's home healthcare subsidiary, EdenTec. "Melville sleep lab products are an excellent strategic fit with EdenTec portable sleep products and the recently acquired Pierre Medical therapeutic products," Nellcor's CEO Raymond Larkin says.
More from Archive
• By
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
• By
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
• By
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
More from Medtech Insight
• By
Only 16% of venture capital general partners in Europe are women, and only 9% of those have actual investment power. Thena Capital is aiming to "redefine the image of a venture capitalist."
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Exer Labs Inc.’s website marketed its AI-based Exer Scan app to “screen and treat Parkinson’s, TB, Cerebral Palsy and more.” But those claims went well beyond what was allowed under the product’s 510(k) clearance, US regulators say.